Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice

Ammar Kutiyanawalla, Wanwisa Promsote, Alvin V Terry, Anilkumar R Pillai

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.

Original languageEnglish (US)
Pages (from-to)1073-1086
Number of pages14
JournalInternational Journal of Neuropsychopharmacology
Volume15
Issue number8
DOIs
StatePublished - Sep 1 2012

Fingerprint

Neurologic Mutant Mice
Cysteamine
Brain-Derived Neurotrophic Factor
Frontal Lobe
Hippocampus
Schizophrenia
trkB Receptor
Glutamate Decarboxylase
Spatial Memory
Drinking Water
Cognition
Neurons

Keywords

  • BDNF
  • GAD67
  • TrkB
  • cognition
  • cysteamine
  • mice
  • reeler

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Psychiatry and Mental health

Cite this

Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice. / Kutiyanawalla, Ammar; Promsote, Wanwisa; Terry, Alvin V; Pillai, Anilkumar R.

In: International Journal of Neuropsychopharmacology, Vol. 15, No. 8, 01.09.2012, p. 1073-1086.

Research output: Contribution to journalArticle

@article{965907759d684baaaedd31d0f31aa476,
title = "Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice",
abstract = "Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.",
keywords = "BDNF, GAD67, TrkB, cognition, cysteamine, mice, reeler",
author = "Ammar Kutiyanawalla and Wanwisa Promsote and Terry, {Alvin V} and Pillai, {Anilkumar R}",
year = "2012",
month = "9",
day = "1",
doi = "10.1017/S1461145711001180",
language = "English (US)",
volume = "15",
pages = "1073--1086",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "8",

}

TY - JOUR

T1 - Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice

AU - Kutiyanawalla, Ammar

AU - Promsote, Wanwisa

AU - Terry, Alvin V

AU - Pillai, Anilkumar R

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.

AB - Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.

KW - BDNF

KW - GAD67

KW - TrkB

KW - cognition

KW - cysteamine

KW - mice

KW - reeler

UR - http://www.scopus.com/inward/record.url?scp=84864570507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864570507&partnerID=8YFLogxK

U2 - 10.1017/S1461145711001180

DO - 10.1017/S1461145711001180

M3 - Article

VL - 15

SP - 1073

EP - 1086

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 8

ER -